The price of Wave Life Sciences Ltd. (NASDAQ: WVE) closed at $5.26 in the last session, down -8.36% from day before closing price of $5.74. On the day, 528128 shares were traded.
Ratios:
We take a closer look at WVE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.26 and its Current Ratio is at 1.26. In the meantime, Its Debt-to-Equity ratio is 0.68 whereas as Long-Term Debt/Eq ratio is at 0.53.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on December 19, 2023, Upgraded its rating to Outperform and sets its target price to $12 from $5 previously.
On July 05, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $7.
Jefferies Downgraded its Buy to Hold on May 24, 2023, whereas the target price for the stock was revised from $7 to $5.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 03 ’24 when Moran Kyle sold 15,630 shares for $6.17 per share. The transaction valued at 96,421 led to the insider holds 33,921 shares of the business.
RA CAPITAL MANAGEMENT, L.P. bought 1,000,000 shares of WVE for $5,000,000 on Dec 11 ’23. The Director now owns 19,202,009 shares after completing the transaction at $5.00 per share. On Dec 07 ’23, another insider, GSK plc, who serves as the 10% Owner of the company, bought 3,300,000 shares for $5.00 each. As a result, the insider paid 16,500,000 and bolstered with 13,983,761 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 5.68 while its Price-to-Book (P/B) ratio in mrq is 15.82.
Stock Price History:
Over the past 52 weeks, WVE has reached a high of $7.67, while it has fallen to a 52-week low of $3.15.
Shares Statistics:
A total of 119.16M shares are outstanding, with a floating share count of 96.36M. Insiders hold about 21.20% of the company’s shares, while institutions hold 74.64% stake in the company.
Earnings Estimates
The company has Cenovus Energy Inc analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $5.26, with high estimates of $19.18 and low estimates of $0.25.
Analysts are recommending an EPS of between $Financial Services and $Consumer Defensive for the fiscal current year, implying an average EPS of $Healthcare.
